RESEARCH TRIANGLE PARK, NC - UK-based GlaxoSmithKline, which has U.S. headquarters in the RTP, has purchased Stiefel Laboratories of Coral Gables, FL, for $2.9 billion. (more…)

ATLANTA, Ga.- Altea Therapeutics announced today that it has entered into an agreement with Eli Lilly and Company and Amylin Pharmaceuticals, Inc. to develop and commercialize a novel daily transdermal patch delivering sustained levels of exenatide utilizing the Altea Therapeutics proprietary PassPort® Transdermal Delivery System. (more…)

Research Triangle Park, NC– Pharma giants GlaxoSmithKline and Pfizer will be combining their HIV portfolio to create a new company. The Raleigh News & Observer reported that the U.S. headquarters of the new venture will be in Research Triangle Park. (more…)

The University of Florida’s Technology Licensing office held its version of speed dating Tuesday. But instead of matching prospective mates, the Celebration of Innovation Showcase touted the virtues of university research inventions and spin-off companies to prospective entrepreneurs and investors.

Despite the down economy, the event grew in its third year, with 339 registrants, up by about 100 people. That included more investors, with representatives from 20 venture capital firms, inventors, entrepreneurs and service providers such as attorneys, according to tech licensing director David Day. (more…)

Greensboro, N.C.– Piedmont Pharmaceuticals LLC, a specialty pharmaceuticals company focused on parasitology and drug delivery systems for companion animal and human use, has successfully raised $5 million in equity financing led by CM Capital Investments of Brisbane, Australia. (more…)